Sign in

CIK 0001082554 · Large accelerated filer

UNITED THERAPEUTICS Corp

Sign in to watch
Ticker
UTHR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
521984749
Phone
3016089292
Business address
1000 SPRING ST, SILVER SPRING, MD, 20910
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$347,711,405
in 75 filings, $346.9M under 10b5-1 plans

Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-17 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −892 $542.06 $484K 324,736
2026-07-17 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −293 $542.43 $159K 324,443
2026-07-17 ROTHBLATT MARTINE A Chairperson & CEO Option exercise · Stock Option 10b5-1 −9,500 322,410
2026-07-16 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 10b5-1 +9,500 $135.42 $1.3M 333,943
2026-07-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −80 $527.31 $42K 333,863
2026-07-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −1,400 $528.42 $740K 332,463
2026-07-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −3,057 $529.46 $1.6M 329,406
2026-07-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −1,924 $530.14 $1.0M 327,482
2026-07-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −520 $532.14 $277K 326,962
2026-07-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −440 $533.28 $235K 326,522
2026-07-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −1,198 $534.31 $640K 325,324
2026-07-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −720 $535.20 $385K 324,604
2026-07-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −150 $536.29 $80K 324,454
2026-07-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −11 $537.11 $6K 324,443
2026-07-16 ROTHBLATT MARTINE A Chairperson & CEO Option exercise · Stock Option 10b5-1 −9,500 331,910
2026-07-16 MAHON PAUL A EVP & GENERAL COUNSEL Option exercise 10b5-1 +8,300 $146.03 $1.2M 53,472
2026-07-16 MAHON PAUL A EVP & GENERAL COUNSEL Sale 10b5-1 −600 $527.60 $317K 52,872
2026-07-16 MAHON PAUL A EVP & GENERAL COUNSEL Sale 10b5-1 −120 $529.81 $64K 52,752
2026-07-16 MAHON PAUL A EVP & GENERAL COUNSEL Sale 10b5-1 −861 $531.97 $458K 51,891
2026-07-16 MAHON PAUL A EVP & GENERAL COUNSEL Sale 10b5-1 −800 $532.94 $426K 51,091

Page 66 of 121 · 2,404 trades